|
Surviving Sepsis Campaign: COVD-19 ARDS Infographic https://www.sccm.org/SurvivingSepsisCampaign/Guidelines/COVID-19  Surviving Sepsis Campaign: COVD-19 Hypoxia Management Infographic https://www.sccm.org/SurvivingSepsisCampaign/Guidelines/COVID-19  Surviving Sepsis Campaign: COVD-19 Therapeutic Updates Infographic https://www.sccm.org/SurvivingSepsisCampaign/Guidelines/COVID-19  Hypodermoclysis: An alternative to IV infusion therapy
Hypodermoclysis, which can also be called interstitial infusion or subcutaneous infusion, is the subcutaneous administration of fluids to the body, often saline or glucose solutions. Hypodermoclysis can be used where a slow rate of fluid uptake is required compared to intravenous infusion. Typically, it is limited to 1 ml per minute, although it is possible to increase this by using two sites simultaneously. The chief advantages of hypodermoclysis over intravenous infusion is that it is cheap and can be administered by non-medical personnel with minimal supervision. It is therefore particularly suitable for home care. The enzyme hyaluronidase can be added to the fluid to improve absorption during hypodermoclysis.
  Advantages of HDC over IV:
Disadvantages of HDC:
 Blood Transfusion Thresholds ■ Sepsis: 7 g/dL ■ Upper or lower GI bleeds: 7 g/dL ■ Acute neurologic injury or TBI : 7 g/dL ■ Stable CV disease: 8 g/dL ■ ACS: 10 g/dL  |
Author
|
